#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Scleroderma associated digital ulcer Osteosarcoma metastatic Adenocarcinoma pancreas Adrenoleukodystrophy Breast angiosarcoma Hereditary motor and sensory neuropathy Cortical dysplasia Myxoid liposarcoma Ewing's sarcoma recurrent Meningococcal immunisation B-cell lymphoma refractory Glomerulonephritis rapidly progressive Cluster headache Pancreatic carcinoma Head and neck cancer More trials…
Learn about Rare Diseases

Ewing’s sarcoma metastatic – Trials in Disease Mucopolysaccharidosis II Medulloblastoma recurrent – Basic Information Small intestine leiomyosarcoma – Trials in Disease Leukoencephalopathy – Diagnostics Toxic epidermal necrolysis – Trials in Disease Retinitis pigmentosa – Basic Information Gaucher’s disease type III Congenital hypotransferrinaemia – Treatment Congenital nephrogenic diabetes insipidus – Treatment More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

Bleomycin Citicoline Sodium Labetalol Hydrochloride Nitric Oxide Fidanacogene Elaparvovec Enzalutamide Amniotic Membrane, Human Cisatracurium Besilate Zidovudine Rupatadine Thiamine Hydrochloride Mesenchymal Cells Metoprolol Tartrate Propylene Glycol Gemcitabine Pitolisant OSIMERTINIB MESYLATE Indacaterol Maleate Sodium Butyrate AZD5335 More therapies…

Learn about Your Condition

Hodgkin's disease refractory Abdominal pain Exfoliation glaucoma Peptostreptococcus infection Fibromyalgia Erdheim-Chester disease Peritoneal abscess Pleural mesothelioma malignant Choroidal neovascularisation Fallopian tube cancer Invasive breast carcinoma Small intestine carcinoma CADASIL Factor IX deficiency Dystonic tremor More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe
🇦🇹 Austria
🇭🇷 Croatia
🇨🇿 Czech Republic
🇩🇰 Denmark
🇪🇪 Estonia
🇫🇮 Finland
🇫🇷 France
🇩🇪 Germany
🇮🇸 Iceland
🇮🇹 Italy
🇱🇻 Latvia
🇱🇹 Lithuania
🇳🇱 Netherlands
🇳🇴 Norway
🇵🇱 Poland
🇵🇹 Portugal
🇷🇴 Romania
🇸🇰 Slovakia
🇸🇮 Slovenia
🇪🇸 Spain
🇸🇪 Sweden

Transitional cell carcinoma urethra

Study on the Safety and Effects of XL092 with Nivolumab, Ipilimumab, and Relatlimab for Patients with Advanced Solid Tumors

Recruiting

1 1 1 1
Investigated Drugs:
+1
Study on Enfortumab Vedotin and Pembrolizumab for Patients with Advanced Urothelial Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
Investigated Drugs:
- Enfortumab Vedotin
- Pembrolizumab
Study of Enfortumab Vedotin and Pembrolizumab for Patients with Advanced or Metastatic Urothelial Cancer

Not recruiting

3 1 1 1
Investigated Diseases:
Investigated Drugs:
+4
Study Comparing Sacituzumab Govitecan with Other Treatments for Patients with Advanced Unresectable Urothelial Cancer

Not recruiting

3 1 1 1
Investigated Diseases:
Investigated Drugs:
+2

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Transitional cell carcinoma urethra

Study on the Safety and Effects of XL092 with Nivolumab, Ipilimumab, and Relatlimab for Patients with Advanced Solid Tumors

Study on Enfortumab Vedotin and Pembrolizumab for Patients with Advanced Urothelial Cancer

Study of Enfortumab Vedotin and Pembrolizumab for Patients with Advanced or Metastatic Urothelial Cancer

Study Comparing Sacituzumab Govitecan with Other Treatments for Patients with Advanced Unresectable Urothelial Cancer

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies